Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients
NCT ID: NCT07130981
Last Updated: 2025-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2025-09-01
2026-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer
NCT00769951
Multimodal Program for Cancer Related Cachexia Prevention
NCT04627376
Routine Evaluation of People Living With Cancer
NCT04406662
"Can Do" Versus "Do Do" in Patients With Breast Cancer
NCT06018051
Body Mass Index (BMI) and Quality of Life (QoL) in Cancer Patients
NCT03873064
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having undergone a CT scan (at the L3 level) prior to treatment
* No severe mental disorder and able to communicate effectively
* Provided written informed consent
Exclusion Criteria
* Patients deemed unsuitable by the physician
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
İzgi Bayraktar
PhD candidate
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University Faculty of Pharmacy, Department of Clinical Pharmacy
Ankara, Altındağ, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SBA 25/672
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.